ReviewOncology and therapy2021

How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer.

Michael Untch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.